Pharma Business Week articles from December 2004

Pharma Business Week archives from December 2004

VELCADE gets fast track status for relapsed and refractory mantle cell lymphoma.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (MLNM) announced that the U.S. Food and Drug Administration (FDA) has granted VELCADE fast track designation for relapsed and refractory mantle cell lymphoma, an...

Scientists have discovered several novel potent NCX inhibitors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger According to recent research published in the journal Bioorganic &...

Report: Clinical trial inefficiencies cost drug companies millions.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Each additional day a drug spends in clinical development could cost companies - $600,000 for a small or niche drug and upwards of $8 million for a blockbuster - in lost revenue, according to recent...

Cervical cancer's image as a niche market hinders drug development.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., has found that, because of slow-to-change treatment strategies and a low burden of disease in developed countries, interest in trials of novel agents for invasive cervical...

Neugene antisense drugs reported to suppress influenza A virus.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced that Qing Ge, PhD, of the Massachusetts Institute of Technology (MIT) Center for Cancer Research, presented data characterizing the effect of AVI's Neugene drugs...

Cancer vaccine helped patients in phase IIb trial survive 4.4 months longer.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) and Merck KGaA reiterated that data from the companies' phase IIb BLP 25 Liposome vaccine (L-BLP25) trial in patients with Stage IIIb and IV non-small cell lung cancer (NSCLC)...

Cocaine pharmacology and pharmacotherapies for its abuse reviewed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers review cocaine pharmacology and current pharmacotherapies for its abuse in a recent issue of Bioorganic and Medicinal Chemistry. "Cocaine abuse continues to be prevalent and effective...

Company licenses oral drug to treat impulse control disorder.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Somaxon Pharmaceuticals, Inc. has licensed the North American rights to oral nalmefene hydrochloride from Biotie Therapies Corp. for the treatment of impulse control disorders. Nalmefene is a...

Long-term use of depo-provera contraceptive injection may cause osteoporosis.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) announced on November 17, 2004, that a "black box" warning will be added to the labeling of Depo-Provera Contraceptive Injection, indicating that prolonged...

Study patients clear African sleeping sickness parasite in DB289 phase IIb trial.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMM) announced that all 30 patients participating in the concluded phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness...

Clinical trial study for PreHistin to begin.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cobalis Corp. (CLSC), a pharmaceutical company specializing in the development of antiallergy medications, announced the start of a 6-week clinical trial study with 624 patients, as a part of the...

Pharma companies collaborate on Alzheimer and Parkinson disease candidates.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- NeuroSearch (NEUR.CO) is collaborating with Boehringer Ingelheim (BI) to develop the drug candidate NS2330 for the treatment of Alzheimer and Parkinson diseases. As an important part of the...

Taking statin slowed progression of Alzheimer disease, new study shows.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A new study has found evidence that taking a commonly prescribed cholesterol-lowering statin drug slowed cognitive decline and improved depressive symptoms in patients with mild to moderate Alzheimer...

ALS drug candidate Myogane gets U.S. FDA Fast Track designation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Phytopharm plc (NASDAQ:PHYOF)(LSE:PYM) (Phytopharm) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its drug candidate PYM50018 (Myogane) for the...

Study: FG-2216 increases endogenous EPO production in humans.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- FibroGen, Inc., announced that oral administration of FG-2216, the company's investigational therapy for anemia, was safe and well-tolerated and significantly increased production of endogenous...

Earlier cardiac catheterization reduces risk of mortality in high-risk patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Earlier and more aggressive treatment for patients at high risk of heart attack can reduce their chances of dying during hospitalization, but such treatment often is underutilized, new Cleveland...

Preclinical data of Antrin to treat vulnerable plaque presented at AHA.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (NASDAQ:PCYC) announced preclinical findings demonstrating that Antrin (motexafin lutetium) angiophototherapy leads to regression and stabilization of vulnerable plaques in various...

Company completes first phase of ThraxVax design.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Circle Group Holdings, Inc., (CXN) has completed the phase I design of its homeland security technology, ThraxVac, and produced a prototype model and promotional DVD for interested buyers. The DVD...

New technology promises to cut time in discovery of antibody drugs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Affitech AS, the human antibody discovery and development company, launched a technology at BioEurope 2004 that promises to dramatically cut the time needed to discover new antibody drugs and their...

Collaboration for aspirin-resistance testing announced.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Corgenix Medical Corp. (CONX) and AspirinWorks, a division of Creative Clinical Concepts, Inc., (CCC), both headquartered in Denver, Colorado, announced that together they have entered into a license...

QVAR in patented Easi-Breathe inhaler launches in United Kingdom.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- IVAX Corporation (IVX) announced the launch of its asthma medicine QVAR in its patented Easi-Breathe inhaler in the United Kingdom. IVAX has been selling QVAR in the United Kingdom, Ireland, France,...

Vaginal dryness can be treated for menopausal women who suffer from condition.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- According to a new Harris Interactive survey, approximately 71% of women over 45 attribute the pain or discomfort they experience during sex to a menopausal symptom called atrophic vaginitis. The...

IRH data presented at International Congress on Autoimmune Diseases.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Hollis-Eden Pharmaceuticals, Inc., (HEPH) presented new data at the Fourth International Congress on Autoimmune Diseases in Budapest, Hungary, on the potential role of immune regulating hormones (IRHs)...

Generic drug maker named Best Overall Pharmaceutical Products Manufacturer.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Par Pharmaceutical Companies, Inc., (NYSE:PRX), a leading developer, manufacturer and marketer of generic pharmaceuticals, has won the 2004 DIANA Award for Best Overall Pharmaceutical Products...

Patient monitoring system wins Innovations 2005 Design and Engineering Honors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- St. Jude Medical, Inc. (STJ) announced that the Housecall Plus remote patient monitoring system has been named an Innovations 2005 Design and Engineering Showcase honoree, the highest accolade of the...

Technology Council names biotech company early stage company of the year.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- PTC Therapeutics, Inc., (PTC) announced that it has been selected by the New Jersey Technology Council (NJTC) as the 2004 Early Stage company of the Year. The award was presented at the NJTC Awards...

CRO names VP of project management, Joseph Parks.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Clinimetrics Research Associates, Inc., has named Joseph Parks vice president of project management for global operations. "In leading our project management department, Joseph brings over 17 years...

Pharma companies will look to public institutions for productivity help in 2005.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- According to Life Science Insights (LSI), an IDC company, 2005 will see a continued evolution of the private/public funding model within drug discovery and development. The discovery model for...

Promising data presented on phase 2 trial drug for superficial bladder cancer.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc. (SPPI) announced encouraging efficacy and safety data from the ongoing multi-center phase 2 trial of EOquin as a single agent in patients with recurrent superficial...

Anti-infective technologies company receives NASDAQ noncompliance notification.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc. (VITX), a biotechnology company developing anti-infective technologies, reported that the NASDAQ Stock Market, Inc. had notified the company that it does not comply with the...

Accelerated partial breast irradiation new option for breast cancer patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Women diagnosed with breast cancer must weigh the options between old tried- and-true and next-generation breast cancer treatments An estimated 216,000 American women will be diagnosed with breast...

Plasma prolactin levels associated with increased postmenopausal disease risk.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Study findings suggest that plasma prolactin levels are associated with increased postmenopausal risk of breast cancer. "Prolactin is important in human breast development, and substantial...

Biopharma reports third quarter 2004 results, clinical achievements.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (NASDAQ: PGNX) announced its results of operations for the third quarter ended September 30, 2004, and for the first 9 months of 2004. Revenues for the third...

Biopharmaceutical company reports third quarter financial, operating results.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- IntraBiotics Pharmaceuticals, Inc., (IBPI) reported financial and operating results for the third quarter and 9 months ended September 30, 2004. IntraBiotics reported a net loss applicable to common...

Biopharmaceuticals company announces third quarter results, progress made.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Keryx Biopharmaceuticals announced its financial results for the third quarter ended Sept. 30, 2004. At Sept. 30, 2004, Keryx announced cash, cash equivalents, interest receivable and investment...

Biotech company announces restructured agreement for cancer drug.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals announced that it has restructured its agreement with Eli Lilly and Company with respect to the royalties payable to Lilly on sales of Ligand's marketed cancer drug Ontak...

Biotech company reports loss of $0.03 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) reported financial results for the first fiscal quarter ended September 30, 2004. The company also reported several achievements during the last quarter, both...

Company reports Q3 results, provides MS-325 regulatory update.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- EPIX Pharmaceuticals, Inc., (EPIX), a developer of pharmaceuticals for magnetic resonance imaging (MRI), announced its financial results for the third quarter 2004 and provided an update on the...

Company reports increase in income and revenue; discusses Inveresk merger.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Charles River Laboratories International, Inc., (CRL) reported third-quarter 2004 net sales of $176.0 million, a 16.4% increase over the $151.2 million reported in the third quarter of 2003. Net...

Company reports third quarter results, Chrysalin product activities.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- OrthoLogic Corp. announced results for the third quarter ended Sept. 30, 2004. It also updated its product development activities related to its Chrysalin Product Platform. OrthoLogic reported a...

Dermatology pharmaceutical company announces financing, new hires.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Neosil Incorporated announced that it closed a $32 million placement of series A Preferred Stock to a group of investors led by MPM Capital and Burrill & Company. The financing will enable Neosil...

Managed care company announces third quarter results up 261%.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- NationsHealth, Inc., (NASDAQ:NHRX) announced financial results for its third quarter ended September 30, 2004. Net revenue for the third quarter of 2004 was $20.1 million, up 261% over the third...

Microcatheter systems developer receives notice from Nasdaq regarding bid price.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cardima, Inc., (Nasdaq SC: CRDM) reported that it has received written notice from Nasdaq that, in accordance with Nasdaq Marketplace Rule 4310(c)(8)(D), the company was provided an additional 180 days,...

Newborn health company reports third quarter revenue and earnings.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Natus Medical Incorporated (Nasdaq:BABY) reported financial results for the 3 and 9 months ended September 30, 2004. Revenue increased 18%, or $1.3 million, to $9.0 million for the third quarter...

Pharmaceutical company reports fourth quarter loss of $0.28 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) announced operating results and revenues for the fourth fiscal quarter and year ended September 30, 2004. Revenues for the quarter were $883,598 as compared to...

Pharmaceutical firm reports loss of $0.18 per share.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ariad Pharmaceuticals, Inc., (ARIA) announced consolidated financial results for the quarter ended September 30, 2004, and provided an overview of the clinical development of AP23573. "In the third...

Prochieve maker provides Q3 report, updates PROTERM study.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories, Inc., (CBRX) announced financial results for the third quarter and 9 months ended September 30, 2004. Highlights of the quarter included: 1) Net sales of $5.1 million, a...

Pharmaceutical sector looks to improve cash management and reduce risk.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Volatility in the pharmaceutical industry, caused by factors ranging from merger activity to recent reports of aggressive accounting issues at high-profile companies, has increased industry credit risk...

ARICEPT maker launches marketing sub in India.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Eisai Co., Ltd., announced that on October 27, 2004, it has established its pharmaceuticals marketing subsidiary, Eisai Pharmaceuticals India Private, Ltd., in India. In India, Eisai...

Biotech establishes new business units for pain and oncology.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals announced that it has established separate therapeutically focused business units for its pain and oncology products. Patrick M. Shea, formerly vice president of marketing,...

Biotechnology company enters strategic marketing agreement with Body Blue.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Helix BioMedix (HXBM.OB) has entered into a strategic marketing agreement with Body Blue, Inc., under which Body Blue will market a wide array of proprietary Helix BioMedix peptides for use in a number...

Company raises over $25M, announces CCP Worldwide merger.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Dyadic International, Inc., (DYAD), a biotechnology company focused on the discovery, development, and manufacturing of proteins and other biological products for industrial and biopharmaceutical...

Dendrite inks reseller agreement.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- MedManage Systems, Inc., a provider of prescription drug-sampling solutions, and Dendrite International, Inc., (DRTE), a provider of clinical, marketing, and sales solutions for the pharmaceutical...

European drug developer awards $1.4M study to ECG services company.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has been awarded a thorough phase I ECG study...

Molecular diagnostics company announces expansion of diagnostic pipeline.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Third Wave Technologies Inc. (TWTI) provided new details about the expansion of the company's molecular diagnostic pipeline and issued preliminary guidance for 2005 clinical molecular diagnostic...

New company to develop, produce patient-specific cancer vaccines.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Baylor Health Care System announced its formation of a cancer immunotherapy company, known as ODC Therapy, Inc. ODC will develop, produce and distribute customized cancer vaccines, including a...

Patient recruitment firm reports 33% increase in patient panel.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Acurian, Inc., a full-service provider of site and patient recruitment solutions, announced that its proprietary patient panel now contains more than 8 million people in the U.S. who are actively...

Sigma-Aldrich catalog, safety data available in integrated software database.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Synthematix, Inc., a provider of chemistry reaction planning and electronic laboratory notebook (ELN) systems for scientific knowledge management, announced that Sigma-Aldrich's (SIAL) catalog and...

European cancer organization offers guidelines for treating anemia.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- New European Organization for Research and Treatment of Cancer (EORTC) guidelines aim to assist physicians in managing anemia more effectively in their patients with cancer by providing advice on the...

Listeria-based cancer vaccines segregate immunogenicity from toxicity.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Listeria-based cancer vaccines segregate immunogenicity from toxicity. According to a study from the United States, "The facultative intracellular bacterium Listeria monocytogenes is being developed...

Freezor MAX obtains FDA approval in the U.S.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., announced that its Freezor MAX catheter device has received premarket application supplement approval from the U.S. Food and Drug Administration (FDA), allowing the company...

Company says implantable defibrillators are cost-effective treatment for heart failure patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Medtronic announced that additional scientific data demonstrate that implantable cardioverter-defibrillators (ICDs) are a cost-effective therapy for heart failure patients. In March 2004, results...

Pharmaceutical company reports on atherosclerosis clinical trail.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals commented on the results of the ARBITER 2 study, which was conducted by Walter Reed Army Medical Center and presented during the 2004 Scientific Sessions of the American Heart...

Study shows differences in cardiovascular risk among cox-2 inhibitors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Research published in a recent issue of Atherosclerosis showed cox-2 inhibitor Vioxx caused biochemical changes that contribute to the development of heart disease, while Celebrex, another cox-2...

Addition of INTEGRILIN provides superior platelet inhibition with stenting.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (NASDAQ:MLNM) announced that in the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR Platelets) trial, the addition of INTEGRILIN, a...

Nanobacterial link to abnormal calcification described in newly released book.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Nanobac Life Sciences, Inc., (OTCPK:NNBP) announced the release of The Calcium Bomb, a book that gives general audiences a view of the nanobacterial link to abnormal calcification affecting millions of...

By impounding iron, FHC foils cell suicide, fuels inflammation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A research team based at the University of Chicago may have found a way to manipulate cell suicide, also known as programmed cell death, a normal process that regulates cell number but that goes awry in...

Millennium, German pharma will work together on cell line development.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- ProBioGen AG, Berlin, Germany, announced that it has entered into a cell line development program with Millennium Pharmaceuticals, Inc., of Cambridge, Massachusetts, USA. Under the customized...

Deep brain stimulation introduced as treatment of neurological disorders.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A small multi-channel recording and stimulating device developed in London may hold the future to improving the lives of people with neurological disorders such as Parkinson Disease, Tourette Syndrome,...

Phase 2 attention deficit hyperactivity disorder study completed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- NeuroSearch (NEUR.CO) has completed a clinical phase II study with NS2359. The study comprised 126 adult attention deficit hyperactivity disorder (ADHD) patients of whom one half were treated with...

Primary endpoint achieved in phase 3 trial of genasense plus chemotherapy.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Genta Incorporated (NASDAQ:GNTA) announced that the company's randomized phase 3 clinical trial of Genasense (oblimersen sodium) Injection in patients with relapsed or refractory chronic lymphocytic...

Ulcerative colitis product report receives gastroenterology society award.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Otsuka Maryland Research Institute, Inc., (OMRI) announced that a poster on its investigational product in development for ulcerative colitis (UC), OPC-6535, was selected as a winner of the American...

Agreement signed to codevelop Tandabs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Affimed Therapeutics AG, a Heidelberg, Germany-based drug development company, has signed a partnership agreement with the biopharmaceutical unit of Syngenta AG of Basel, Switzerland, to codevelop one...

Anti-cancer vaccine R&D agreement signed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- IDM (Immuno-Designed Molecules) announced the signing of a research and development agreement with the Walter Reed Army Institute of Research involving the development of an anti-cancer vaccine...

Biopharma delivers candidate, achieves research milestone with Organon.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Pharmacopeia Drug Discovery, Inc., (NASDAQ:PCOP) has achieved a milestone in its research collaboration with Organon, the human healthcare business of Dutch Akzo Nobel (NASDAQ:AKZOY). Pharmacopeia...

Dyax announces antibody discovery collaboration.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Dyax Corp. (DYAX) announced a research collaboration to provide Biogen Idec (BIIB) with access to Dyax's fully human antibody libraries for the purpose of identification and characterization of...

Manufacturing agreement signed for pharmaceutical siRNA.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Acuity Pharmaceuticals, Inc., a product-focused ophthalmic pharmaceutical company, announced that it has signed a long-term manufacturing agreement with Avecia Biotechnology, Inc., for pharmaceutical...

Nanotechnology companies ink broad cross-licensing pact.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Two emerging nanotechnology companies announced a broad cross-licensing agreement that will extend the market reach and technical utility of their fluorescent biomolecular assaying platforms. ...

Nonprofit tissue banking organizations form partnership to benefit community.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Two nonprofit leaders in tissue banking, Musculoskeletal Transplant Foundation (MTF) and Northwest Tissue Center, announced a new agreement to make MTF's proprietary tissue grafts more accessible to...

Pharmaceutical companies enter collaboration to develop digestive enzymes.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Solvay Pharmaceuticals and Novozymes A/S have entered a collaboration to develop new products for enzyme replacement therapy for patients suffering from pancreatic exocrine insufficiency due to cystic...

Research software deal signed for new materials characterization software.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., (ACCL) and the University of Cambridge announced the signing of two exclusive agreements that will enable Accelrys to provide researchers with a new method to aid the characterization of...

Service agreement signed with Lexicon Pharmaceuticals.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- ActiveSight announced that it has entered into an agreement to provide protein crystallography services to Lexicon Pharmaceuticals. The agreement is focused on co-crystallography of certain of...

ELOXATIN approved for colon cancer treatment following surgery.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Sanofi-Synthelabo, a member of the sanofi-aventis Group, announced that the U.S. Food and Drug Administration (FDA) has approved ELOXATIN, in combination with conventional chemotherapy (infusional...

Non-compliance reported to cause 125,000 hospital, nursing home deaths annually.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Patient non-compliance is a growing issue that annually contributes up to 125,000 deaths and up to 20% of all hospital and nursing home admissions. According to a new report from Cutting Edge...